AAAAAA

   
Results: 1-11 |
Results: 11
Cell proliferation markers in human solid tumors: Assessing their impact in clinical oncology
Authors: Daidone, MG Costa, A Silvestrini, R
Citation: Mg. Daidone et al., Cell proliferation markers in human solid tumors: Assessing their impact in clinical oncology, METH CELL B, 64, 2001, pp. 359-384
Relevance of DNA-ploidy as a prognostic instrument for solid tumors
Authors: Silvestrini, R
Citation: R. Silvestrini, Relevance of DNA-ploidy as a prognostic instrument for solid tumors, ANN ONCOL, 11(3), 2000, pp. 259-261
Cell proliferation and outcome following doxorubicin plus CMF regimens in node-positive breast cancer
Authors: Silvestrini, R Luisi, A Zambetti, M Cipriani, S Valagussa, P Bonadonna, G Daidone, MG
Citation: R. Silvestrini et al., Cell proliferation and outcome following doxorubicin plus CMF regimens in node-positive breast cancer, INT J CANC, 87(3), 2000, pp. 405-411
Biomarkers and outcome after tamoxifen treatment in node-positive breast cancers from elderly women
Authors: Daidone, MG Luisi, A Martelli, G Benini, E Veneroni, S Tomasic, G De Palo, G Silvestrini, R
Citation: Mg. Daidone et al., Biomarkers and outcome after tamoxifen treatment in node-positive breast cancers from elderly women, BR J CANC, 82(2), 2000, pp. 270-277
Clinical studies of Bcl-2 and treatment benefit in breast cancer patients
Authors: Daidone, MG Luisi, A Veneroni, S Benini, E Silvestrini, R
Citation: Mg. Daidone et al., Clinical studies of Bcl-2 and treatment benefit in breast cancer patients, ENDOCR-R CA, 6(1), 1999, pp. 61-68
International consensus statement on testing and reporting of antineutrophil cytoplasmic antibodies (ANCA)
Authors: Savige, J Gillis, D Benson, E Davies, D Esnault, V Falk, RJ Hagen, EC Jayne, D Jennette, JC Paspaliaris, B Pollock, W Pusey, C Savage, COS Silvestrini, R van der Woude, F Wieslander, J Wiik, A
Citation: J. Savige et al., International consensus statement on testing and reporting of antineutrophil cytoplasmic antibodies (ANCA), AM J CLIN P, 111(4), 1999, pp. 507-513
Clinical utility of anticardiolipin antibody assays: High inter-laboratoryvariation and limited consensus by participants of external quality assurance programs signals a cautious approach
Authors: Favaloro, EJ Silvestrini, R Mohammed, A
Citation: Ej. Favaloro et al., Clinical utility of anticardiolipin antibody assays: High inter-laboratoryvariation and limited consensus by participants of external quality assurance programs signals a cautious approach, PATHOLOGY, 31(2), 1999, pp. 142-147
Atypical C-ANCA following high dose intravenous immunoglobulin
Authors: Jolles, S Deacock, S Turnbull, W Silvestrini, R Bunn, C White, P Ward, M
Citation: S. Jolles et al., Atypical C-ANCA following high dose intravenous immunoglobulin, J CLIN PATH, 52(3), 1999, pp. 177-180
Biological markers as indicators of response to primary and adjuvant chemotherapy in breast cancer
Authors: Daidone, MG Veneroni, S Benini, E Tomasic, G Coradini, D Mastore, M Brambilla, C Ferrari, L Silvestrini, R
Citation: Mg. Daidone et al., Biological markers as indicators of response to primary and adjuvant chemotherapy in breast cancer, INT J CANC, 84(6), 1999, pp. 580-586
Prognostic and predictive value of thymidine labelling index in breast cancer
Authors: Amadori, D Silvestrini, R
Citation: D. Amadori et R. Silvestrini, Prognostic and predictive value of thymidine labelling index in breast cancer, BREAST CANC, 51(3), 1998, pp. 267-281
UCN-01 abrogates G(2) arrest through a Cdc2-dependent pathway that is associated with inactivation of the Wee1Hu kinase and activation of the Cdc25C phosphatase
Authors: Yu, LJ Orlandi, L Wang, P Orr, MS Senderowicz, AM Sausville, EA Silvestrini, R Watanabe, N Piwnica-Worms, H O'Connor, PM
Citation: Lj. Yu et al., UCN-01 abrogates G(2) arrest through a Cdc2-dependent pathway that is associated with inactivation of the Wee1Hu kinase and activation of the Cdc25C phosphatase, J BIOL CHEM, 273(50), 1998, pp. 33455-33464
Risultati: 1-11 |